Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92006761 | 9200676 | 1 | I | 20130128 | 20130319 | 20130331 | 20130331 | EXP | GB-TEVA-393858ISR | TEVA | 83.00 | YR | M | Y | 0.00000 | 20130331 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92006761 | 9200676 | 1 | PS | LANSOPRAZOLE | 1 | UNKNOWN | U | 77255 | 30 | MG | CAPSULE | ||||||||
| 92006761 | 9200676 | 2 | C | Atenolol | 1 | UNKNOWN | D | 0 | 50 | MG | |||||||||
| 92006761 | 9200676 | 3 | C | Ramipril | 1 | UNKNOWN | D | 0 | 5 | MG |
Indications of drugs used
| no results found |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 92006761 | 9200676 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92006761 | 9200676 | Infected skin ulcer | |
| 92006761 | 9200676 | Skin ulcer | |
| 92006761 | 9200676 | Wound complication |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92006761 | 9200676 | 1 | 2013 | 0 |